PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Neighborhood stressors dangerously elevate pregnancy hormones

2023-11-03
(Press-News.org) Pregnant women living in blighted neighborhoods with high levels of known stressors have higher levels of testosterone – the primary sex hormone in males -- which disrupt hormone regulation and may lead to life-threatening complications during and after childbirth, according to Rutgers research. 

“Previous research has shown that exposure to neighborhood stressors is associated with preterm birth, low birth weight and other complications such as preeclampsia, gestational diabetes and stillbirth,” said Zorimar Rivera Núñez, an assistant professor of epidemiology at the Rutgers School of Public Health and a senior author of the study published in BMC Pregnancy and Childbirth.

“The purpose of this study was to look at possible mechanisms between neighborhood stressors and pregnancy health, and we looked at sex steroid hormones because they’re critically important for both fetal development and maternal health,” Rivera-Núñez said.

Researchers analyzed data from 262 pregnant women who completed a questionnaire about their neighborhoods and underwent blood tests that measured sex hormones such as testosterone in each trimester.

The researchers found that women living in neighborhoods with stressors such as vacant lots, derelict buildings and other signs of disorder had significantly higher levels of testosterone – nearly 40 percent higher by the third trimester of pregnancy – than women living in well-ordered neighborhoods.

Testosterone is known to play a role in a variety of pregnancy-related processes, including sexual differentiation of the brain during early development.

Megan Hansel, first author and doctoral student at the Rutgers School of Public Health, said their findings suggest interventions to reduce neighborhood stress, such as improving access to green spaces and community resources, could help to improve pregnancy outcomes for all pregnant people.

In addition to the potential physical health risks for pregnant people and their babies, neighborhood stress also can harm maternal mental health, previous studies show. Pregnant people living in stressful neighborhoods are more likely to experience anxiety, depression and other mental health problems. These mental health problems also can hurt pregnancy outcomes.

Data for the study come from the Understanding Pregnancy Signals and Infant Development (UPSIDE) cohort, which collected biospecimens, questionnaires and medical record data from 262 women living in and around Rochester, N.Y. Researchers measured the sex hormones maternal serum total testosterone, free testosterone, estrone, estradiol and estriol in each trimester and surveyed participants about neighborhood stressors. UPSIDE is part of the NIH program Environmental Influences on Child Health Outcomes (ECHO), the largest study on child health in the U.S.

The new analysis of UPSIDE data found that 73 percent of women in the cohort reported exposure to one or more types of neighborhood disorder, while 22 percent reported any exposure to violence.

In adjusted models, neighborhood disorder was associated with higher testosterone across pregnancy, with the strongest associations observed in the third trimester, where neighborhood disorder was associated with an average testosterone elevation of 38 percent. The effect was more pronounced in women carrying male rather than female fetuses.

Exposure to violence wasn’t associated with any hormones.

“The findings suggest that stress may alter prenatal testosterone levels, which could explain some of the adverse outcomes we find when pregnant people live with neighborhood stressors,” Rivera Núñez said. “But more research is needed to prove a causal link.”

END


ELSE PRESS RELEASES FROM THIS DATE:

Are results from clinical trials in kidney transplant recipients applicable to the real world?

2023-11-03
Highlights Investigators have found demographic differences between participants of kidney transplant clinical trials and transplant recipients in the United States, even in recent years. Results from the study will be presented at ASN Kidney Week 2023 November 1–November 5. Philadelphia, PA (November 3, 2023) — Investigators recently examined the extent to which participants in clinical trials related to kidney transplantation are similar to individuals undergoing transplantation in the United States. The ...

County-level structural racism may affect mortality rates in people with kidney failure

2023-11-03
Highlights In a recent analysis of US data, Black patients with kidney failure experienced survival advantages compared with White patients when county-level structural racism was low, but they experienced survival disadvantages compared with White patients at higher levels of structural racism. Results from the study will be presented at ASN Kidney Week 2023 November 1–November 5. Philadelphia, PA (November 3, 2023) — A new analysis indicates that county-level structural racism is a significant determinant of death among individuals ...

Is high urinary albumin linked to sub-clinical cardiovascular disease in people with type 2 diabetes?

2023-11-03
Highlights Imaging tests in individuals with type 2 diabetes without symptoms of cardiovascular disease indicated that elevated albumin in the urine may be linked with sub-clinical coronary artery pathology, including coronary artery microcalcifications. Results from the study will be presented at ASN Kidney Week 2023 November 1–November 5. Philadelphia, PA (November 3, 2023) — Advances in non-invasive imaging have allowed clinicians to assess both the structure and function of coronary arteries. Investigators who recently used positron emission tomography and computed tomography ...

Scientists create the most complete atlas of the human fetal kidney to date

2023-11-03
Highlights By examining the gene expression patterns of single cells from human fetal kidneys, researchers created a map that demonstrates the trajectories of cell states in the developing kidney and that identifies characteristics associated with kidney diseases. Results from the study will be presented at ASN Kidney Week 2023 November 1–November 5. Philadelphia, PA (November 3, 2023) — Scientists have examined the gene expression patterns of single cells from 5 human fetal kidneys to create the most complete atlas of the ...

Sotagliflozin protects kidney and heart in patients with type 2 diabetes and chronic kidney disease

2023-11-03
Highlights Results from the phase 3 SCORED trial indicate that sotagliflozin protects kidney and heart health in individuals with type 2 diabetes and chronic kidney disease. Results from the study will be presented at ASN Kidney Week 2023 November 1–November 5. Philadelphia, PA (November 3, 2023) — Sodium-glucose cotransporter-2 (SGLT2) inhibitors, which are medications that lower blood sugar levels among other effects, provide kidney- and heart-related benefits to patients with and without diabetes. An exploratory analysis ...

HAARP artificial airglow may be widely visible in Alaska

2023-11-03
Alaskans and visitors may be able to see an artificial airglow in the sky created by the High-frequency Active Auroral Research Program during a four-day research campaign that starts Saturday. Scientists from the University of Alaska Fairbanks, Cornell University, University of Colorado Denver, University of Florida and Georgia Institute of Technology will conduct a variety of experiments at the UAF-operated research site. The experiments will focus on the ionosphere, the region of the atmosphere between about 30 and 350 miles ...

Management of recurrent gastrointestinal cancer with ripretinib and surgery

Management of recurrent gastrointestinal cancer with ripretinib and surgery
2023-11-03
“The patient was managed with ripretinib and surgical resection of progressing lesions at multiple time points which led to extended clinical benefit.” BUFFALO, NY- November 3, 2023 – A new case report was published in Oncoscience (Volume 10) on September 20, 2023, entitled, “Multi-disciplinary management of recurrent gastrointestinal stromal tumor harboring KIT exon 11 mutation with the switch-control kinase inhibitor ripretinib and surgery.” Ripretinib is a tyrosine kinase inhibitor that was approved by the United States FDA in 2020 for treatment of advanced ...

Transforming the food system to serve all

2023-11-03
Health happens where people work, live, play and worship, says Prof. Stacey Snelling, chair of the Department of Health Studies in American University’s College of Arts and Sciences. And that’s where the Healthy Schools, Healthy Communities Lab engages children, adults and older adults to tackle health inequities. Snelling received a three-year grant of $2.8 million from Novo Nordisk Inc. for health education and to grow the number of Black farmers producing locally grown fruit and vegetables. The goal is to improve local ...

Oncology researchers raise ethics concerns posed by patient-facing Artificial Intelligence

2023-11-03
BOSTON – Ready or not, patients with cancer are increasingly likely to find themselves interacting with artificial intelligence technologies to schedule appointments, monitor their health, learn about their disease and its treatment, find support, and more. In a new paper in JCO Oncology Practice, bioethics researchers at Dana-Farber Cancer Institute call on medical societies, government leaders, clinicians, and researchers to work together to ensure AI-driven healthcare preserves patient autonomy and respects human dignity. The authors note that while AI has immense potential for expanding access to cancer care and improving the ...

New radiopharmaceutical shows antitumor activity in patients with advanced prostate cancer

2023-11-03
Researchers at Weill Cornell Medicine have led a phase 1 trial of a new drug that delivers potent radiation therapy directly and specifically to cancer cells in patients with advanced prostate cancer. The clinical trial showed that the “radiopharmaceutical” was well tolerated and demonstrated promising antitumor activity, according to a new study published on Nov. 2 in the Journal of Clinical Oncology. The radiopharmaceutical 225AC-J591 was administered in a single injection and consists of two parts: an antibody that helps find the cancer cells is linked to a molecule that delivers a deadly dose of radiation. Specifically, an antibody named J591 that ...

LAST 30 PRESS RELEASES:

Innovative risk score accurately calculates which kidney transplant candidates are also at risk for heart attack or stroke, new study finds

Kidney outcomes in transthyretin amyloid cardiomyopathy

Partial cardiac denervation to prevent postoperative atrial fibrillation after coronary artery bypass grafting

Finerenone in women and men with heart failure with mildly reduced or preserved ejection fraction

Finerenone, serum potassium, and clinical outcomes in heart failure with mildly reduced or preserved ejection fraction

Hormone therapy reshapes the skeleton in transgender individuals who previously blocked puberty

Evaluating performance and agreement of coronary heart disease polygenic risk scores

Heart failure in zero gravity— external constraint and cardiac hemodynamics

Amid record year for dengue infections, new study finds climate change responsible for 19% of today’s rising dengue burden

New study finds air pollution increases inflammation primarily in patients with heart disease

AI finds undiagnosed liver disease in early stages

The American Society of Tropical Medicine and Hygiene and the Bill & Melinda Gates Foundation announce new research fellowship in malaria genomics in honor of professor Dominic Kwiatkowski

Excessive screen time linked to early puberty and accelerated bone growth

First nationwide study discovers link between delayed puberty in boys and increased hospital visits

Traditional Mayan practices have long promoted unique levels of family harmony. But what effect is globalization having?

New microfluidic device reveals how the shape of a tumour can predict a cancer’s aggressiveness

Speech Accessibility Project partners with The Matthew Foundation, Massachusetts Down Syndrome Congress

Mass General Brigham researchers find too much sitting hurts the heart

New study shows how salmonella tricks gut defenses to cause infection

Study challenges assumptions about how tuberculosis bacteria grow

NASA Goddard Lidar team receives Center Innovation Award for Advancements

Can AI improve plant-based meats?

How microbes create the most toxic form of mercury

‘Walk this Way’: FSU researchers’ model explains how ants create trails to multiple food sources

A new CNIC study describes a mechanism whereby cells respond to mechanical signals from their surroundings

Study uncovers earliest evidence of humans using fire to shape the landscape of Tasmania

Researchers uncover Achilles heel of antibiotic-resistant bacteria

Scientists uncover earliest evidence of fire use to manage Tasmanian landscape

Interpreting population mean treatment effects in the Kansas City Cardiomyopathy Questionnaire

Targeting carbohydrate metabolism in colorectal cancer: Synergy of therapies

[Press-News.org] Neighborhood stressors dangerously elevate pregnancy hormones